When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation

Eur Ann Allergy Clin Immunol. 2019 May 15;51(3):135-137. doi: 10.23822/EurAnnACI.1764-1489.88.
No abstract available

Keywords: Real-life; discontinuation; mepolizumab; monoclonal antibodies; severe asthma.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aminophylline / therapeutic use
  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / drug therapy*
  • Biological Products / therapeutic use*
  • Bronchodilator Agents / therapeutic use
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Prednisone / therapeutic use
  • Recurrence
  • Withholding Treatment*

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • Bronchodilator Agents
  • Glucocorticoids
  • Aminophylline
  • mepolizumab
  • Prednisone